TurkNet Selects Zyxel Communications for GPON-FTTH Expansion
13.10.2020 08:00:00 EEST | Business Wire | Press release
Zyxel Communications announced TurkNet implemented its GPON-FTTH equipment and Fibre Access Solution to connect subscribers with more bandwidth and faster speeds.
“Zyxel’s Fibre Access Solution offers a variety of different connectivity options. This gives us the flexibility to easily deploy services on GPON, Active Fibre solutions with OLT, ONU/ONT and active fibre gateways included in our roadmap,” said Mustafa Uçar, Chief Technology Officer at TurkNet. “We did not face any problems in the implementation process, and Zyxel’s technical teams were very helpful and easy to work with throughout. We recommend Zyxel to our worldwide ISP colleagues without hesitation.”
Founded in 1996, TurkNet is one of Turkey's 100 largest IT companies and an innovative, next-generation telecom operator. TurkNet’s robust, high-capacity network and widespread backup system connects more than 300,000 subscribers throughout the country with access to high-speed internet.
To expand connectivity options for subscribers, TurkNet sought an affordable, high-performance solution that could fit into a highly competitive market such as GPON-FTTH. Having previous experience with Zyxel’s portfolio of DSL solutions, TurkNet added Zyxel’s OLT1404A/OLT1408A 4/8-port GPON OLT, PMG 1005, IES5212M-ZZ01V1F to its suite of products.
TurkNet selected Zyxel because its fixed-line CPE is equipped for both DSL and Fibre services. This gave TurkNet additional flexibility as it transitions towards a fibre network and offers innovative products for subscribers. The company also indicated Zyxel’s strong local presence and customer support as reasons for its decision.
“Zyxel provided a reasonably priced product that fit our requirements, and they had a great local team who helped us throughout the deployment process,” says Sinan Kurmuş, Chief Consumer Business Unit Officer, TurkNet.
About Zyxel Communications
Zyxel delivers technological innovations and has connected the world to the Internet for more than 30 years. Whether it’s a matter of establishing access through fixed or mobile broadband solutions, at Zyxel we offer a comprehensive and flexible portfolio of products that’s right for Service Providers and their customers. To learn more, visit https://zyxel.eu/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201012005778/en/
Contact information
Media Contact
Birgitte Dolevert Larsen
Zyxel Communications
birgitte.larsen@zyxel.eu
+45 2085 9223
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
euNetworks launches new quantum-safe private connectivity service powered by Adtran’s encrypted optical transport technology27.5.2026 11:00:00 EEST | Press release
Adtran and euNetworks today announced their collaboration on the launch of a new quantum-safe private connectivity service, Quantum Shield. euNetworks has developed Quantum Shield using Adtran’s optical transport technology to augment its broader architecture, which is designed to deliver secure, scalable data center connectivity across euNetworks’ pan-European network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526610601/en/ Adtran’s encrypted optical transport technology is helping euNetworks deliver the highest levels of protection for sensitive data moving across Europe. The new offering is built for enterprises with stringent security, performance and customer-controlled encryption requirements. The deployment combines high-capacity dedicated infrastructure with real-time fiber monitoring and enhanced optical-layer visibility to safeguard critical traffic. By integrating advanced encryption with continuous monito
National Bank of Greece in Cyprus Goes Live With Smartstream’s Air to Consolidate Reconciliations27.5.2026 10:55:00 EEST | Press release
Smartstream, the trusted data solutions provider for leading global financial institutions and enterprises, today announces that the National Bank of Greece (NBG) in Cyprus has successfully gone live with Air, the company’s AI-enabled reconciliation solution. The go-live marks a significant step forward in the bank’s operational efficiency, reducing daily manual processing effort and eliminating the complexity of working across multiple data formats. The bank has deployed Air’s Cash module, replacing both incumbent and consolidating four separate reconciliation systems for Instant, Cash, SEPA, and Nostro reconciliations, into a single, intelligent platform. Although transaction volumes were manageable, the fragmented landscape required significant daily manual effort to handle items individually across each system and to navigate multiple data formats. Following a market review, the bank committed to Smartstream’s Air, with self service model and AI-enabled automation being a distinct
Duco Launches the First Agentic Operations Platform for Financial Services27.5.2026 10:20:00 EEST | Press release
Duco, today launched the first agentic Operations platform for financial services. Built on the engine that already processes 20 billion transactions every month for more than 200 clients, including seven of the top 20 banks and ten of the top 20 asset managers, the platform brings together everything firms need to run post-trade Operations alongside autonomous agents, safely and at scale. The launch establishes a breakthrough the industry has been waiting for. A tool surface, purpose-built for agents. Duco has unbundled its platform into a new alternative agent layer that reconfigures its platform into hundreds of discrete capabilities servicing post trade. Model Context Protocol (MCP) gives capabilities covering reconciliation, data preparation, data access, audit trails, exception management, document creation and more. For the first time, agents have a verified, deterministic toolset built specifically for post-trade. Agents do not replace matching, rules or audit; they use them. P
Brenus Pharma Announces FDA Acceptance of IND Application for STC-1010 (BreAK-CRC001) in MSS Metastatic Colorectal Cancer (mCRC)27.5.2026 09:49:00 EEST | Press release
Brenus Pharma, a clinical stage biotechnology company developing novel in vivo immunotherapies for solid tumors, announced that the U.S. Food and Drug Administration (FDA) has accept the company's Investigational New Drug (IND) application for its first drug candidate, STC-1010, in microsatellite stable (MSS) metastatic colorectal cancer (mCRC). STC-1010 is designed to address a critical unmet need worldwide. Approximately 95% of mCRC patients have MSS tumors, which demonstrate minimal response to standard immunotherapies. The FDA validated Brenus Pharma's advanced regulatory and manufacturing capabilities. This operational readiness will accelerate patient access and data generation across both European and US sites for a Phase II program planned for 2027. "FDA's acceptance of our IND represents a major validation of our program and enables the full execution of our clinical strategy across Europe and the United States. Achieving regulatory alignment across multiple jurisdictions refl
Alfasigma presents first data on filgotinib from the Phase 3 OLINGUITO trial in axial spondyloarthritis at EULAR 202627.5.2026 09:00:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare and specialty care where there is significant unmet patient need, presented positive results from the OLINGUITO Phase 3 clinical trial (NCT05785611iEudraCT 2022-501354-10-01ii) at EULAR 2026. In OLINGUITO filgotinib, an oral, once-daily JAK1 preferential inhibitor under investigation for the treatment of adult patients with active axial spondyloarthritis (axSpA), demonstrated sustained improvements in the signs and symptoms of axSpA, including disease activity and inflammation.iii Safety was consistent with the known profile of filgotinib, indicating a favourable benefit-risk profile for patients with active axSpA.iii The OLINGUITO trial consists of two international, randomised, double-blind, placebo-controlled studies (Study A and Study B), evaluating the efficacy and safety of filgotinib 200mg once-daily vs. placebo in patients with an established diagnosis of axSpA as per ASAS classification.i Eligi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom